Interpace Biosciences Inc Rövid arány
Mi az Interpace Biosciences Inc Rövid arány?
A Rövid arány az Interpace Biosciences Inc - 0.19
Mi a Rövid arány meghatározása?
A rövid arány az értékesített részvények rövid száma, az átlagos napi mennyiséggel elosztva.
Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.
The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.
Rövid arány a Health Care szektor a NASDAQ-on cégekben a Interpace Biosciences Inc -hoz képest
Mit csinál Interpace Biosciences Inc?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
rövid arány -hoz hasonló cégek Interpace Biosciences Inc
- Australian REIT Income Fund nak Rövid arány 0.18 van
- Enlighta nak Rövid arány 0.18 van
- Tearlach Resources nak Rövid arány 0.18 van
- Academy Metals nak Rövid arány 0.18 van
- Guangshen Railway Co nak Rövid arány 0.18 van
- BlackRock Municipal Income Investment Quality Trust nak Rövid arány 0.18 van
- Interpace Biosciences Inc nak Rövid arány 0.19 van
- PowerOre nak Rövid arány 0.20 van
- ALX Resources nak Rövid arány 0.20 van
- Serabi Gold plc nak Rövid arány 0.20 van
- Gratomic nak Rövid arány 0.20 van
- Benton Resources nak Rövid arány 0.20 van
- Act II Global Acquisition nak Rövid arány 0.20 van